Tuesday’s Midday Movers: Orexigen (OREX), Rosetta Genomics Ltd (ROSG), American Green Inc (ERBB), Renesola (SOL), Weatherford (WFT)

By Carrie Williams

So far Tuesday, December 4, NASDAQ is down -5.59% and the S&P is down -4.02%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Orexigen (OREXResearch Report), Rosetta Genomics Ltd (ROSGResearch Report), American Green Inc (ERBBResearch Report), Renesola (SOLResearch Report) and Weatherford (WFTResearch Report).

Orexigen is up 71.43% in midday trading to $0.01. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.00. Over the last 3 months, the insider sentiment on Orexigen has been negative based on 3 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Rosetta Genomics Ltd is up 25% in midday trading to $0.00. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

American Green Inc is up 25% in midday trading to $0.00. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

See today’s analyst top recommended stocks >>

Renesola is down -9.32% in midday trading to $1.46. Shares opened today at $1.61. The company has a 52-week low of $1.31 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.75, marking a 8.70% potential upside from current levels. In a report issued on November 19, Roth Capital analyst Justin Clare reiterated a Hold rating on SOL, with a price target of $1.75, which represents a potential upside of 9% from where the stock is currently trading.

Weatherford is down -8.94% in midday trading to $0.55. Shares opened today at $0.60. The company has a 52-week low of $0.55 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $2.08, marking a 244.37% potential upside from current levels. In a report issued on November 16, Jefferies Co. analyst Brad Handler maintained a Hold rating on WFT, with a price target of $0.75, which implies an upside of 24% from current levels. Separately, on November 5, BMO’s Daniel Boyd reiterated a Buy rating on the stock and has a price target of $2.50.

See today’s analyst top recommended stocks >>

Trending Stocks Based on Insider Activity >>